date,title,source
Nov-08-18,Entera Bio Reports Positive Results from Part 1 of a Phase 2 PK/PD Study of Oral PTH (1-34) in Patients with Hypoparathyroidism,GlobeNewswire
Dec-11-18,Entera shares jump 11.5% on news of collaboration with Amgen,MarketWatch
Dec-11-18,Entera Bio and Amgen Enter Strategic Research Collaboration in Inflammatory Disease and Other Serious Illnesses,GlobeNewswire
Jan-10-19,Entera Bio Appoints Gerald M. Ostrov to Board of Directors,GlobeNewswire
Jan-22-19,Entera Bio Reports Third Quarter 2018 Financial Results and Operating Update,GlobeNewswire
Jan-31-19,Entera Bio Announces Positive Feedback and Guidance from the US FDA Regarding its Development Plans for Oral PTH in Osteoporosis,GlobeNewswire
Mar-07-19,Entera Bio Announces a Transition in the Chief Financial Officer Position,GlobeNewswire
Mar-27-19,"Entera Bio to Announce Fourth Quarter and Year Ended December 31, 2018 Financial Results on Thursday, March 28",GlobeNewswire
